Target intelligence / Profile preview

Herpes simplex virus 1 entry receptors

Molecular classification
Receptor, Tumor necrosis factor receptor superfamily, Immunoglobulin superfamily, Glycosaminoglycan, Cell adhesion molecule
01

Overview

Host cell receptors for HSV-1 entry are a diverse group of cell surface molecules that facilitate the multi-step process of Herpes Simplex Virus type 1 (HSV-1) infection. The process begins with the attachment of viral glycoproteins gB and gC to heparan sulfate proteoglycans (HSPGs) on the host cell surface [1, 9]. This is followed by the binding of viral glycoprotein D (gD) to one of several specific entry receptors, including Nectin-1 (also known as Poliovirus receptor-related protein 1), Herpesvirus entry mediator (HVEM, a member of the TNF receptor superfamily), or 3-O-sulfated heparan sulfate [2, 3, 7]. These interactions trigger a conformational change in gD that recruits the core fusion machinery (gB and the gH/gL complex), leading to the fusion of the viral envelope with the host plasma membrane or endosomal membrane [1, 12]. Different receptors are utilized depending on the cell type; for example, Nectin-1 is the primary receptor for epithelial and neuronal cells, while HVEM is critical for entry into T lymphocytes [3, 12]. Targeting these receptors or their interactions with viral glycoproteins is a key area of antiviral research, with drugs like docosanol acting as fusion inhibitors and various experimental peptides and small molecules designed to block attachment or receptor binding [4, 10, 18].

Other names
Host cell receptors for HSV-1 entryHSV-1 entry receptorsgD receptorsNectin-1 (PVRL1, HveC)Herpesvirus entry mediator (HVEM, TNFRSF14, HveA)3-O-sulfated heparan sulfate (3-OS HS)Heparan sulfate proteoglycans (HSPG)Nectin-2 (PVRL2, HveB)Paired immunoglobulin-like type 2 receptor alpha (PILRα)Non-muscle myosin heavy chain IIA (NMHC-IIA)Myelin-associated glycoprotein (MAG)
02

Mechanism of action

Inhibition of viral-host membrane fusion, blocking of viral attachment to cell surface proteoglycans, and downregulation of receptor expression.

03

Biological functions

Viral entryCell adhesionImmune response regulationSignal transductionCell-cell adhesion
04

Disease associations

InfectionHerpes labialisHerpes simplex keratitisHerpes simplex encephalitisGenital herpes
05

Safety considerations

Potential for immunosuppression due to HVEM's role in T-cell signalingDisruption of cell-cell adhesion and tissue integrity due to Nectin-1 inhibitionOff-target effects on endogenous glycosaminoglycan functions
06

Interacting drugs

Docosanol

5 more in the full profile.

07

Biomarkers

Nectin-1 expressionHVEM expression3-O-sulfated heparan sulfate levels

Beyond the preview

Go deeper on Herpes simplex virus 1 entry receptors.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Herpes simplex virus 1 entry receptors.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call